Almirall, S.A. Logo

Almirall, S.A. (ALM)

BME

Currency in EUR
10.06
-0.20 (-1.95%)

Closed

Oct 8, 2026

Day's Range

10.06
10.24

52 wk Range

10.02
13.98

Overview - ALM - Almirall, S.A.

Key Statistics

Valuation

Enterprise Value

2.27B

P/E (Trailing)

‪37.28‬

P/E (Forward)

‪19.37‬

PEG Ratio

‪19.37‬

Price / Sales (TTM)

‪1.96‬

Price / Book

‪1.48‬

EV / EBITDA

‪10.31‬

Profitability

Gross Margin

‪185.11%‬

Profit Margin

‪5.11%‬

Operating Margin

‪13.33%‬

Return on Assets

‪2.69%‬

Return on Equity

‪3.95%‬

Ownership

Shares Outstanding

217.60M

Float

78.27M

Held by Insiders

‪64.07%‬

Held by Institutions

‪16.53%‬

Price stats

Beta

‪0.16‬

50-Day Avg

‪10.65‬

200-Day Avg

‪11.83‬

Dividends

Payout Ratio

‪67.59%‬

Frequency

Annual

Analyst Consensus

Buy

12 analysts

Average price target

‪€ 14.30‬

News Teaser - ALM - Almirall, S.A.

News & Analysis

View all news

Market Cap - ALM - Almirall, S.A.

Peers - ALM - Almirall, S.A.

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on BME.

Profile Summary - ALM - Almirall, S.A.

About

Almirall, S.A. is a Spanish pharmaceutical company specializing in medical dermatology, headquartered in Barcelona and founded in 1944. It focuses on researching, developing, manufacturing, and marketing innovative medicines to address unmet needs in skin health, particularly for conditions like psoriasis, atopic…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees2.09K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.